Review of therapeutic properties of emetine in nonamoebic infections.
D002761:Cholangitis / Q000188:drug therapy; D002764:Cholecystitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003015:Clostridium Infections / Q000188:drug therapy; D004640:Emetine / Q000627:therapeutic use*; D004927:Escherichia coli Infections / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008100:Liver Abscess / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013530:Surgical Wound Infection / Q000188:drug therapy
D004640:Emetine